Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK)

STK10 (serine/threonine kinase 10, LOK), is an important regulator of diverse cellular processes, such as cell cycle progression and lymphocyte migration. STK10 has emerged as a potential therapeutic target for diseases associated with impaired cell migration and cell division. Here, we present a late-stage optimization of a macrocyclic pyrazolo-[1,5-<i>a</i>]-pyrimidine scaffold that led to a urea-based lead series targeting the back-pocket of STK10. Co-crystal structure analysis of <b>23</b> revealed that the optimized macrocycles adopted a unique binding mode that protrudes deep into the back-pocket of STK10. Compound <b>23</b> exhibited potent on-target activity in biophysical and activity assays and displayed nanomolar activity for STK10 in cells. In addition, <b>23</b> shows good selectivity against the kinome and remarkably also against the closely related kinase SLK (STE20-like kinase). Therefore, we propose that targeting the unique and largely extended pocket in STK10 represents an opportunity to develop highly selective STK10 inhibitors.

Authors

Institutions

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2025-10-14
DOI
https://doi.org/10.1021/acsmedchemlett.5c00479
Citations
1
Primary Topic
NF-κB Signaling Pathways
Type
article
Field-Weighted Citation Impact
0.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK)

L M Wahl, Christian Georg Kurz, Stefan Knapp, Krishna Saxena et al.
1 citations
ACS Medicinal Chemistry Letters
NF-κB Signaling Pathways
0.94
article

Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK)

L M Wahl, Christian Georg Kurz, Stefan Knapp, Krishna Saxena, Martina Dettenhöfer, Christopher Lenz, Benedict‐Tilman Berger, Martin Schröder, Martin P. Schwalm, Susanne Müller, Lewis Elson, Jennifer Alisa Amrhein, Thomas Hanke, Andreas Krämer, Joshua Gerninghaus, Francesco Greco, Theresa Elisabeth Mensing, Laura Nadine Tandara
article en
1 citations

Abstract

STK10 (serine/threonine kinase 10, LOK), is an important regulator of diverse cellular processes, such as cell cycle progression and lymphocyte migration. STK10 has emerged as a potential therapeutic target for diseases associated with impaired cell migration and cell division. Here, we present a late-stage optimization of a macrocyclic pyrazolo-[1,5-<i>a</i>]-pyrimidine scaffold that led to a urea-based lead series targeting the back-pocket of STK10. Co-crystal structure analysis of <b>23</b> revealed that the optimized macrocycles adopted a unique binding mode that protrudes deep into the back-pocket of STK10. Compound <b>23</b> exhibited potent on-target activity in biophysical and activity assays and displayed nanomolar activity for STK10 in cells. In addition, <b>23</b> shows good selectivity against the kinome and remarkably also against the closely related kinase SLK (STE20-like kinase). Therefore, we propose that targeting the unique and largely extended pocket in STK10 represents an opportunity to develop highly selective STK10 inhibitors.

ACS Medicinal Chemistry LettersVol. 16(11)
Goethe University Frankfurt (DE), German Cancer Research Center (DE), Frankfurt Institute for Advanced Studies (DE), German Cancer Society (DE)
Openalex Percentile: Top 20%
NF-κB Signaling Pathways
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.